NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to stop devastating Flare-Ups in rare brain disease
Disease control Recruiting nowThis study tests an injection called B001 in 132 people with neuromyelitis optica spectrum disorder (NMOSD), a rare disease that causes attacks of inflammation in the eyes and spinal cord. The goal is to see if the drug can delay or prevent these attacks. Participants must have h…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Engineered immune cells take on multiple sclerosis and more in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment using specially engineered immune cells (CAR T-cells) that target two proteins, CD19 and BCMA, to calm overactive immune attacks in people with relapsed or hard-to-treat neurological autoimmune diseases like multiple sclerosis, myasthe…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New hope for rare nerve disease: early trial of NouvSoma001 begins
Disease control Recruiting nowThis early-stage trial tests a new treatment called NouvSoma001 for people with neuromyelitis optica spectrum disorder (NMOSD), a rare disease that attacks the nerves in the eyes and spinal cord. The treatment uses tiny particles from stem cells, injected into the spine, to try t…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Super MRI scans aim to unlock secrets of brain resilience
Knowledge-focused Recruiting nowThis study uses powerful MRI scanners to look at the brains of 700 people, including those with conditions like multiple sclerosis, Alzheimer's, and Parkinson's, as well as healthy volunteers. The goal is to understand why some brains stay healthy while others develop disease. Re…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC